Last visit was: 25 Apr 2024, 00:25 It is currently 25 Apr 2024, 00:25

Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
SORT BY:
Date
Tags:
Show Tags
Hide Tags
Math Expert
Joined: 02 Sep 2009
Posts: 92901
Own Kudos [?]: 618867 [9]
Given Kudos: 81588
Send PM
Senior Manager
Senior Manager
Joined: 10 Jan 2017
Posts: 277
Own Kudos [?]: 252 [1]
Given Kudos: 371
Location: India
Send PM
Manager
Manager
Joined: 15 May 2017
Status:Discipline & Consistency always beats talent
Posts: 146
Own Kudos [?]: 124 [1]
Given Kudos: 132
Location: United States (CA)
GPA: 3.59
WE:Sales (Retail)
Send PM
Intern
Intern
Joined: 17 Jul 2018
Posts: 31
Own Kudos [?]: 4 [0]
Given Kudos: 65
Location: India
GMAT 1: 720 Q50 V38
Send PM
Re: Two alternative drugs are available to prevent blood clots from develo [#permalink]
Bunuel wrote:
Two alternative drugs are available to prevent blood clots from developing after a heart attack. According to two major studies, drug Y does this no more effectively than the more expensive drug Z, but drug Z is either no more or only slightly more effective than drug Y. Drug Z’s manufacturer, which has engaged in questionable marketing practices such as offering stock options to doctors who participate in clinical trials of drug Z, does not contest the results of the studies but claims that they do not reveal drug Z’s advantages. However, since drug Z does not clearly treat the problem more effectively than drug Y, there is no established medical reason for doctors to use drug Z rather than drug Y on their heart-attack victims.

Which one of the following principles, if established, would most help to justify a doctor’s decision to use drug Z rather than drug Y when treating a patient?


(A) Only patients to whom the cost of an expensive treatment will not be a financial hardship should receive that treatment rather than a less expensive alternative one.

(B) Doctors who are willing to assist in research on the relative effectiveness of drugs by participating in clinical trials deserve fair remuneration for that participation.

(C) The decision to use a particular drug when treating a patient should not be influenced by the marketing practices employed by the company manufacturing that drug.

(D) A drug company’s criticism of studies of its product that do not report favorably on that product is unavoidably biased and therefore invalid.

(E) Where alternative treatments exist and there is a chance that one is more effective than the other, the possibly more effective one should be employed, regardless of cost.




Why B is wrong? we are asked to strengthen Doctor's decision to prescribe drug Z, which B answers directly.
Whereas E is a generic statement....

Pls explain :)
Manager
Manager
Joined: 06 Aug 2018
Posts: 81
Own Kudos [?]: 14 [0]
Given Kudos: 161
GMAT 1: 600 Q43 V30
GMAT 2: 690 Q49 V35
Send PM
Two alternative drugs are available to prevent blood clots from develo [#permalink]
eakabuah mira93@nighblade354
Was stuck between option A and E.According to you what would be the best reason to eliminate option A?
Senior Manager
Senior Manager
Joined: 18 Sep 2018
Posts: 256
Own Kudos [?]: 200 [0]
Given Kudos: 322
Location: India
Concentration: Finance, International Business
GMAT 1: 690 Q49 V36
GPA: 3.72
WE:Investment Banking (Investment Banking)
Send PM
Two alternative drugs are available to prevent blood clots from develo [#permalink]
Hi Ksmew

Just read the choice again with more thought on the highlighted word:

(B) Doctors who are willing to assist in research on the relative effectiveness of drugs by participating in clinical trials deserve fair remuneration for that participation.


Option B is an opinion and we actually don't know whether Stock Options that the doctors are receiving are fair enough already. In addition, we also don't know whether the money spent on Drug Z would go to the doctors.

Please give kudos, if you like my explanation.
Senior Manager
Senior Manager
Joined: 18 Sep 2018
Posts: 256
Own Kudos [?]: 200 [0]
Given Kudos: 322
Location: India
Concentration: Finance, International Business
GMAT 1: 690 Q49 V36
GPA: 3.72
WE:Investment Banking (Investment Banking)
Send PM
Two alternative drugs are available to prevent blood clots from develo [#permalink]
Hi deveshj21

The question asks in general and choice A restricts the scope.

Question: Which one of the following principles, if established, would most help to justify a doctor’s decision to use drug Z rather than drug Y when treating a patient?

Choice A : (A) Only patients to whom the cost of an expensive treatment will not be a financial hardshipshould receive that treatment rather than a less expensive alternative one.

Hope this helps.
Senior Manager
Senior Manager
Joined: 16 Oct 2020
Posts: 265
Own Kudos [?]: 163 [0]
Given Kudos: 2385
GMAT 1: 460 Q28 V26
GMAT 2: 550 Q39 V27
GMAT 3: 610 Q39 V35
GMAT 4: 650 Q42 V38
GMAT 5: 720 Q48 V41
Send PM
Re: Two alternative drugs are available to prevent blood clots from develo [#permalink]
nightblade354

How can A be eliminated? Since drug Y and drug Z are comparable in terms of efficacy, shouldn't the decision then be based on the cost, which is the distinguishing factor?

Thanks in advance!
Current Student
Joined: 31 Jul 2017
Status:He came. He saw. He conquered. -- Going to Business School -- Corruptus in Extremis
Posts: 1734
Own Kudos [?]: 5738 [0]
Given Kudos: 3054
Location: United States (MA)
Concentration: Finance, Economics
Send PM
Two alternative drugs are available to prevent blood clots from develo [#permalink]
Expert Reply
Two alternative drugs are available to prevent blood clots from developing after a heart attack. According to two major studies, drug Y does this no more effectively than the more expensive drug Z, but drug Z is either no more or only slightly more effective than drug Y. Drug Z’s manufacturer, which has engaged in questionable marketing practices such as offering stock options to doctors who participate in clinical trials of drug Z, does not contest the results of the studies but claims that they do not reveal drug Z’s advantages. However, since drug Z does not clearly treat the problem more effectively than drug Y, there is no established medical reason for doctors to use drug Z rather than drug Y on their heart-attack victims.

Breakdown:

Y: Costs $ and efficacy is 90% (just using round numbers to make visualization easier)

Z: Costs $$ and efficacy is 90% - 92%

A justify question is asking you to say "OK, here is your problem and here is the outcome we want. Find the information in the middle to bridge the gap and make it work". With this model, per the below, we need to justify Z over Y. Well, if we are going to justify it (which means adding a principle or premise) we need to say that cost doesn't matter and that we are going with the best medicine period. This is the only way to justify the claim given the information we have. Best medicine wins is what we are looking for as a principle.


Which one of the following principles, if established, would most help to justify a doctor’s decision to use drug Z rather than drug Y when treating a patient?

(A) Only patients to whom the cost of an expensive treatment will not be a financial hardship should receive that treatment rather than a less expensive alternative one. -- WRONG! We are told here that only patients who can afford the drug should get it. Well, we are choosing Z over Y, so we don't care who can afford it. Our only goal is to say that the best medicine is given to people. Financial hardships don't matter when we're only caring about efficacy.

(E) Where alternative treatments exist and there is a chance that one is more effective than the other, the possibly more effective one should be employed, regardless of cost. -- PERFECT! Parse this out as I did above. If an alternative treatment exists (Y Vs. Z), and there is a chance it is better (Z has at worst equal, if not better, outcomes) then we should choose it regardless of cost. Word for word how we justify Z over Y given the information. Z might be better, but costs way more. How do we justify using it? By saying cost doesn't matter.

achloes, did this help?
CEO
CEO
Joined: 07 Mar 2019
Posts: 2553
Own Kudos [?]: 1813 [0]
Given Kudos: 763
Location: India
WE:Sales (Energy and Utilities)
Send PM
Re: Two alternative drugs are available to prevent blood clots from develo [#permalink]
Two alternative drugs are available to prevent blood clots from developing after a heart attack. According to two major studies, drug Y does this no more effectively than the more expensive drug Z, but drug Z is either no more or only slightly more effective than drug Y. Drug Z’s manufacturer, which has engaged in questionable marketing practices such as offering stock options to doctors who participate in clinical trials of drug Z, does not contest the results of the studies but claims that they do not reveal drug Z’s advantages. However, since drug Z does not clearly treat the problem more effectively than drug Y, there is no established medical reason for doctors to use drug Z rather than drug Y on their heart-attack victims.

Which one of the following principles, if established, would most help to justify a doctor’s decision to use drug Z rather than drug Y when treating a patient?

(A) Only patients to whom the cost of an expensive treatment will not be a financial hardship should receive that treatment rather than a less expensive alternative one. - WRONG. 2nd best but it focusses on cost aspect instead of reason why doctor must use Z over Y. And that too for specific cases only. So, the reasoning offered goes in either direction depending on the situation.

(B) Doctors who are willing to assist in research on the relative effectiveness of drugs by participating in clinical trials deserve fair remuneration for that participation. - WRONG. Bland and irrelevant.

(C) The decision to use a particular drug when treating a patient should not be influenced by the marketing practices employed by the company manufacturing that drug. - WRONG. Morally correct but does not matter. In fact, this goes against Doctor using Z.

(D) A drug company’s criticism of studies of its product that do not report favorably on that product is unavoidably biased and therefore invalid. - WRONG. Irrelevant. Doctor must use Z and that reason in not identifiable here.

(E) Where alternative treatments exist and there is a chance that one is more effective than the other, the possibly more effective one should be employed, regardless of cost. - CORRECT. Cost not playing a role here.

Answer E.
GMAT Club Bot
Re: Two alternative drugs are available to prevent blood clots from develo [#permalink]
Moderators:
GMAT Club Verbal Expert
6920 posts
GMAT Club Verbal Expert
238 posts
CR Forum Moderator
832 posts

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne